Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1307 (LINC01307) is a human gene encoding a long intergenic non-coding RNA transcript. By definition, lincRNAs are RNAs transcribed from genomic regions that do not overlap protein-coding genes and are longer than 200 nucleotides[1][3][5]. LINC01307's function is not fully characterized specifically, but as a member of the lincRNA family, it is likely involved in tissue-specific regulation of gene expression, modulation of chromatin architecture, and may have enhancer-like activity[3][5][9]. Most lincRNAs do not directly interact with drugs or serve as classic therapeutic targets, but they can play important roles in disease by influencing gene expression, cell state, and disease susceptibility[3][9]. There is no current evidence of LINC01307 being used as a drug target, biomarker, or having direct disease associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1307 (LINC01307).